EGFR-Inhib-NSCLC-Treatment Generic

Mobocertinib is this oral deal that helps with Non-Small Cell Lung Cancer (NSCLC), especially in folks who have EGFR Exon 20 insertion mutations. So, the drug goes after the EGFR to try and slow down cancer cell growing. It’s in these little 40 mg capsules, and people usually take 160 mg of it each day.

You can take it with food or not, whatever works for you. These bottles hold 90 capsules per pop. The big idea behind this is to mess with the EGFR’s pathways, the ones that let cancer cells just keep growing wild in folks with this EGFR 20ins mutation.

So, it’s like a super-targeted treatment.